DK0585397T3 - Bombesinanaloger - Google Patents

Bombesinanaloger

Info

Publication number
DK0585397T3
DK0585397T3 DK92913859.2T DK92913859T DK0585397T3 DK 0585397 T3 DK0585397 T3 DK 0585397T3 DK 92913859 T DK92913859 T DK 92913859T DK 0585397 T3 DK0585397 T3 DK 0585397T3
Authority
DK
Denmark
Prior art keywords
bombesin
derivatives
antagonist
methyl
treatment
Prior art date
Application number
DK92913859.2T
Other languages
Danish (da)
English (en)
Inventor
Judson V Edwards
Bradford O Fanger
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0585397T3 publication Critical patent/DK0585397T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086—Bombesin; Related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Silicon Polymers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK92913859.2T 1991-05-23 1992-04-21 Bombesinanaloger DK0585397T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70486391A 1991-05-23 1991-05-23

Publications (1)

Publication Number Publication Date
DK0585397T3 true DK0585397T3 (da) 1997-08-25

Family

ID=24831155

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92913859.2T DK0585397T3 (da) 1991-05-23 1992-04-21 Bombesinanaloger

Country Status (11)

Country Link
US (1) US5428019A (de)
EP (1) EP0585397B1 (de)
JP (1) JP3350701B2 (de)
AT (1) ATE156492T1 (de)
AU (1) AU659659B2 (de)
CA (1) CA2109322C (de)
DE (1) DE69221486T2 (de)
DK (1) DK0585397T3 (de)
ES (1) ES2106188T3 (de)
GR (1) GR3025003T3 (de)
WO (1) WO1992020707A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723578A (en) * 1987-09-24 1998-03-03 The Administrators Of Tulane Educational Fund Peptide analogs of bombesin
US5877277A (en) 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
EP0448677A4 (en) * 1989-09-15 1992-08-26 Biomeasure Inc. Treatment of colon cancer
US5650395A (en) * 1995-03-13 1997-07-22 Hurel; Steven Treatment of pulmonary hypertension
US5786335A (en) * 1995-11-06 1998-07-28 Warner-Lambert Company Sulfhydryl containing peptides for treating vascular disease
US7078413B2 (en) 1996-04-19 2006-07-18 Wisconsin Alumni Research Foundation Compositions and methods of use for a bombesin peptide
US6989371B1 (en) 1996-08-16 2006-01-24 Dabur Research Foundation Bombesin analogs for treatment of cancer
US5861532A (en) * 1997-03-04 1999-01-19 Chiron Corporation Solid-phase synthesis of N-alkyl amides
US7060247B2 (en) * 1997-04-22 2006-06-13 The Curators Of The University Of Missouri Gastrin receptor-avid peptide conjugates
US6200546B1 (en) * 1997-04-22 2001-03-13 The Curators Of The University Of Missouri Gastrin receptor-avid peptide conjugates
CA2300076A1 (en) * 1997-09-16 1999-03-25 Societe Des Produits Nestle S.A. Organ specific nutrition
US7226577B2 (en) * 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
US7611692B2 (en) * 2003-01-13 2009-11-03 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
EP1583564B1 (de) * 2003-01-13 2009-07-01 Bracco Imaging S.p.A Verbesserte linker für radiopharmazeutische verbindungen
US20060239923A1 (en) * 2003-01-13 2006-10-26 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7922998B2 (en) * 2003-01-13 2011-04-12 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US8420050B2 (en) * 2003-01-13 2013-04-16 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7850947B2 (en) * 2003-01-13 2010-12-14 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
WO2004081031A2 (en) * 2003-03-10 2004-09-23 Biogen Idec Inc. Thiol-mediated drug attachment to targeting peptides
CN111500612A (zh) * 2020-03-30 2020-08-07 扬州大学 一种可溶性猪胃泌素释放肽融合蛋白表达载体及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1592552A (en) * 1976-12-10 1981-07-08 Inst Nat Sante Rech Med Pseudopeptides used as medicaments
US4631270A (en) * 1978-11-20 1986-12-23 Research Corporation Therapeutically useful pseudopeptides, compositions containing the same and methods of preparation and use
EP0076557B1 (de) * 1981-06-22 1985-11-13 Imperial Chemical Industries Plc Peptide und Pseudopeptide, die zwei Substituenten am N-Terminus aufweisen
US4871717A (en) * 1987-01-07 1989-10-03 Administrators Of The Tulane Educational Fund Peptides
WO1989002897A1 (en) * 1987-09-24 1989-04-06 The Administrators Of The Tulane Educational Fund Therapeutic peptides
EP0313158A3 (de) * 1987-10-23 1990-08-22 Merck & Co. Inc. Antagonisten von Gastrin freisetzenden Peptiden
US5047502A (en) * 1987-10-23 1991-09-10 Merck And Co., Inc. Gastrin releasing peptide antagonist
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
GB8806644D0 (en) * 1988-03-21 1988-04-20 Imp Cancer Res Tech Neuropeptide antagonists
GB8808768D0 (en) * 1988-04-14 1988-05-18 Erba Carlo Spa Peptide ligands for bombesin receptors
GB8813356D0 (en) * 1988-06-06 1988-07-13 Ici Plc Polypeptide compounds
ZA894533B (en) * 1988-06-20 1990-03-28 Merrell Dow Pharma Neurokinin a antogonists
GR1000608B (el) * 1988-07-21 1992-08-31 Erba Carlo Spa Μεθοδος για την παρασκευη ανταγωνιστων bombesin.
JP2919889B2 (ja) * 1988-10-14 1999-07-19 アドミニストレイターズ オブ ザ テューレイン エデュケイショナル ファンド 治療用ペプチド
US5028692A (en) * 1989-04-25 1991-07-02 Merck & Co., Inc. Gastrin releasing peptide antagonist
EP0452447A1 (de) * 1989-11-06 1991-10-23 FARMITALIA CARLO ERBA S.r.l. Irreversible, reduzierte bombesinantagonisten
CA2030212A1 (en) * 1989-11-22 1991-05-23 Judson V. Edwards Peptides

Also Published As

Publication number Publication date
EP0585397B1 (de) 1997-08-06
ATE156492T1 (de) 1997-08-15
ES2106188T3 (es) 1997-11-01
JP3350701B2 (ja) 2002-11-25
DE69221486T2 (de) 1998-03-19
JPH06508126A (ja) 1994-09-14
CA2109322A1 (en) 1992-11-24
AU659659B2 (en) 1995-05-25
DE69221486D1 (de) 1997-09-11
CA2109322C (en) 2002-11-05
EP0585397A1 (de) 1994-03-09
AU2184092A (en) 1992-12-30
WO1992020707A1 (en) 1992-11-26
US5428019A (en) 1995-06-27
GR3025003T3 (en) 1998-01-30

Similar Documents

Publication Publication Date Title
DK0585397T3 (da) Bombesinanaloger
LU91857I2 (fr) Abarelix, optionnellement sous forme de sel pharmaceutiquement acceptable
ATE284413T1 (de) Therapeutische peptid derivate
SE8703938L (sv) Peptidderivat
MXPA05002991A (es) Analogos de ghrh.
AU3576597A (en) Endoderm, cardiac and neural inducing factors
MX9703642A (es) Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana.
KR880012641A (ko) 아미노산 유도체
ES2012720A6 (es) Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada.
NO942919L (no) Fenylalaninanaloger av bombesin
AU638775B2 (en) Antimitotic and antisecretary peptides that are antagonistic to the peptides bombesin and gastric releasing peptide
CA2022740A1 (en) Cyclic neurokinin a antagonists
WO2003045942A3 (en) Chemokine receptor antagonists and methods of use thereof
EP0347802A3 (de) Neurokinin-A-Antagonisten
NO894720D0 (no) Farmasoeytisk aktivt protein.
ES2104637T3 (es) Peptidos con una actividad antagonista para la bombesina/grp.
BR9911756A (pt) Composto, uso de um secretagogo do hormÈnio do crescimento ou um seu sal farmaceuticamente aceitável, composição farmacêutica, método para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero, e, uso de um composto
WO2002007676A3 (en) Compounds having affinity for the granulocyte-colony stimulating factor receptor (g-csfr)
EP0248231A3 (en) Pharmacologically active peptides
EP0177826A3 (de) Arzneimittel und Diagnostikum mit Wachstumshormon-Releasingfaktor-Wirkung
RU93058426A (ru) Антогонист галанина, способ его получения, пептид, фармацевтический состав и способ лечения
HUP0000271A2 (en) Use of glucagon-like peptide-1 (glp-1) or analogs to abolish catabolic changes after surgery